Robust IPO activity through late 2026, driven by favorable equity market conditions and sustained demand for AI-related capital raises, underpins strong trader consensus on additional listings before year-end. Year-to-date U.S. proceeds have already surpassed prior cycles, with Renaissance Capital tracking over $250 billion across dozens of deals by mid-year, fueled by large offerings like SpaceX. Multiple S-1 filings and scheduled pricings—such as Oura targeting a $2.1 billion Nasdaq debut around September 30 and Anthropic eyeing an October or November window—signal continued momentum into Q4. Lower interest-rate volatility relative to 2022–2024 and healthy secondary-market valuations provide supportive backdrop, though any sharp equity correction or regulatory delays could compress the final-quarter calendar. Key near-term catalysts include Fed communications and earnings season that typically influence issuer timing.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · UpdatedPerplexity remains private with no confirmed IPO before the deadline
Available reporting continues to describe Perplexity as private and its CEO’s stated target as 2028. No official IPO completion or filing by the market deadline was found in the supplied material, supporting the low endpoint price.

































Beware of external links.
Beware of external links.
Frequently Asked Questions